| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| stem cell transplant for aml leukemia | 1.77 | 0.3 | 9219 | 96 | 37 |
| stem | 0.46 | 0.1 | 8444 | 74 | 4 |
| cell | 0.66 | 0.8 | 5492 | 88 | 4 |
| transplant | 1.14 | 0.1 | 6254 | 36 | 10 |
| for | 0.94 | 0.2 | 7277 | 12 | 3 |
| aml | 1.89 | 0.2 | 4175 | 72 | 3 |
| leukemia | 1.39 | 0.1 | 8965 | 21 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| stem cell transplant for aml leukemia | 1.1 | 0.1 | 1987 | 81 |
| can stem cell transplant cure aml | 1.24 | 0.2 | 2041 | 29 |
| bone marrow transplant for aml leukemia | 0.58 | 0.4 | 821 | 38 |
| aml stem cell transplant survival | 0.37 | 0.5 | 1922 | 93 |
| aml stem cell transplant prognosis | 0.31 | 0.7 | 6662 | 55 |
| stem cell transplant for all leukemia | 1.31 | 0.2 | 4142 | 59 |
| stem cell transplant for leukemia patients | 0.69 | 0.7 | 9343 | 84 |
| stem cell transplant for leukemia | 1.26 | 0.3 | 947 | 9 |
| acute myeloid leukemia stem cell transplant | 1.27 | 0.2 | 9207 | 72 |
| aml stem cell transplant survival rate | 0.53 | 0.5 | 5532 | 29 |
| stem cell transplants for leukemia | 1.96 | 0.9 | 564 | 32 |
| bone marrow transplant for aml | 1.28 | 0.1 | 5062 | 3 |
| new treatment for aml leukemia | 1.85 | 0.9 | 2272 | 78 |
| new treatments for aml leukemia | 0.52 | 0.3 | 213 | 19 |
| leukemic stem cells and high risk aml | 1.79 | 0.2 | 8609 | 78 |
| aml and bone marrow transplant | 0.8 | 1 | 411 | 89 |
Only a small decline in one year survival was noted for those over 60 or even over 70 in all donor groups, though the cohorts over age 70 are quite small. A recent focused analysis restricted to patients over 60 with AML in first complete remission analyzed 1330 patients transplanted from 2007 to 2017.
Why are stem cell transplants used as cancer treatment?Why are stem cell transplants carried out? Stem cell transplants are used to treat conditions in which the bone marrow is damaged and is no longer able to produce healthy blood cells. Transplants can also be carried out to replace blood cells that are damaged or destroyed as a result of intensive cancer treatment.
How safe are human embryonic stem cell transplants?TUESDAY, Oct. 14, 2014 (HealthDay News) -- A new study is the first to show the long-term safety of embryonic stem cell transplants to treat human disease. The research involved 18 people who received the transplants to treat forms of macular degeneration, a leading cause of vision loss.
